Results 121 to 130 of about 18,865 (225)

Neurokinin pathway antagonists for vasomotor symptoms in women with breast cancer: focus on elinzanetant and fezolinetant. [PDF]

Breast
Pogoda K, Arecco L, Lambertini M.
europepmc   +1 more source

NK2R signaling governs intestinal lipid mobilization and mucosal inflammation. [PDF]

Elife
Perez PA, Liu CC, Ferrari A, Littlejohn NK, Kennelly JP, Robinson EM, Nguyen-Tran VTB, Athanacio J, Joesph SB, Amso Z, Tontonoz P, Srinivasan S.   +11 more
europepmc   +1 more source

Substance P and NK-1R in Dengue: A First Serological Investigation. [PDF]

Health Sci Rep
Mehboob R, Shahid I, Ahmad S, Sarwar N, John A, Mehboob Z, Almansouri M, Badoghaish W.   +7 more
europepmc   +1 more source

Integrated Computational Modeling Reveals a Structurally Plausible Transient Paclitaxel-NK2R Interaction. [PDF]

Bioengineering (Basel)
Duda-Seiman C, Tartau LM, Hoinoiu B, Pit D, Dumitrascu V, Tanase AD, Rusu E, Luca A, Popa EG, Hoinoiu T.   +9 more
europepmc   +1 more source

Elinzanetant improves sleep in postmenopausal women. So does placebo. [PDF]

Sleep
Lappin JM, Perrault AA, Gordon CJ.
europepmc   +1 more source

Hot flashes: a review. [PDF]

Front Med (Lausanne)
Jamal S, Elsabagh A, Wani L, Issa M.
europepmc   +1 more source

Emerging pharmacological targets in migraine therapy: CGRP and beyond. [PDF]

Front Pharmacol
Atraszkiewicz D, Dahiya D.
europepmc   +1 more source

Elinzanetant: Defining the Role of Dual Neurokinin-1 and Neurokinin-3 Receptor Antagonism for Management of Vasomotor Symptoms in Menopause. [PDF]

J Menopausal Med
Teli V, Teli A.
europepmc   +1 more source

Potential risk of neoplasms with fezolinetant: clinical evidence, mechanisms, and post-marketing implications. [PDF]

J Endocr Soc
Boretti E, Dogné JM, Douxfils J.
europepmc   +1 more source

Delayed and long-delayed chemotherapy-induced nausea and vomiting in moderately emetogenic chemotherapy: a scoping review of reporting gaps. [PDF]

ESMO Open
Iimura Y, Chow R, Watanabe D, Hayashi T, Kuroda S, Jordan K, Ruhlmann CH, Molassiotis A, Affronti ML, Scotté F, Iihara H, MASCC Antiemetic Study Group.   +11 more
europepmc   +1 more source